Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed Conditions
NCT01621763
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Clopidogrel
Sponsor
Dr. Reddy's Laboratories Limited